Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Eledon Pharmaceuticals (ELDN) Assets Average (2016 - 2026)

Eledon Pharmaceuticals filings provide 4 years of Assets Average readings, the most recent being $22.0 million for Q4 2017.

  • On a quarterly basis, Assets Average rose 15.81% to $22.0 million in Q4 2017 year-over-year; TTM through Dec 2017 was $22.0 million, a 15.81% increase, with the full-year FY2017 number at $11.0 million, down 68.07% from a year prior.
  • Assets Average hit $22.0 million in Q4 2017 for Eledon Pharmaceuticals, down from $24.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $107.4 million in Q4 2014 to a low of $13.5 million in Q1 2017.
  • Median Assets Average over the past 4 years was $52.3 million (2016), compared with a mean of $55.3 million.
  • The widest YoY moves for Assets Average: up 15.81% in 2017, down 78.5% in 2017.
  • Eledon Pharmaceuticals' Assets Average stood at $107.4 million in 2014, then crashed by 32.2% to $72.8 million in 2015, then crashed by 73.95% to $19.0 million in 2016, then rose by 15.81% to $22.0 million in 2017.
  • The last three reported values for Assets Average were $22.0 million (Q4 2017), $24.9 million (Q3 2017), and $26.3 million (Q2 2017) per Business Quant data.